CU

Copenhagen University Hospital – Herlev at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Copenhagen University Hospital – Herlev takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on the side effects of immunotherapies beyond immune checkpoint inhibitors. It covers acute and late toxicities of tumour-infiltrating lymphocyte and T-cell receptor therapies in solid tumours.

OrganizationESMO 2026 Attendance
CU
Copenhagen University Hospital – Herlev
Herlev, Denmark
Cancer centre & hospital
Public university hospital in Herlev, near Copenhagen, Denmark, home to a national centre for cancer immune therapy.
Talk
Sat Oct 24
11:44–11:51
Table 3
Mentor the Mentor session
Abstract
Sat Oct 24
16:42–16:54
Invited Discussant LBA1
Presidential Symposium I
Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers
Talk
Sun Oct 25
14:45–15:05
Acute and late toxicities of TILs and TCR therapy in solid tumours
Toxicities of immunotherapies beyond immune checkpoints
Nursing & supportive care
Chair
Sun Oct 25
14:45–16:15
Toxicities of immunotherapies beyond immune checkpoints
with Vall d'Hebron Institute of Oncology (VHIO)
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Copenhagen University Hospital – Herlev

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction